Tevogen Inc. (TVGN) Debt Components
- 2026-06-30: Convertible Notes Payable, CurrentUSD (m); Notes Payable, CurrentUSD $1.65M; Short-term DebtUSD (m); Debt Instrument, Unamortized DiscountUSD (m).
- 2026-03-31: Convertible Notes Payable, CurrentUSD (m); Notes Payable, CurrentUSD $1.65M; Short-term DebtUSD (m); Debt Instrument, Unamortized DiscountUSD (m).
- 2025-12-31: Convertible Notes Payable, CurrentUSD (m); Notes Payable, CurrentUSD $1.65M; Short-term DebtUSD (m); Debt Instrument, Unamortized DiscountUSD (m).
- 2025-09-30: Convertible Notes Payable, CurrentUSD (m); Notes Payable, CurrentUSD $1.65M; Short-term DebtUSD (m); Debt Instrument, Unamortized DiscountUSD (m).
Tevogen Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Convertible Notes Payable, Current USD | Notes Payable, Current USD | Short-term Debt USD | Debt Instrument, Unamortized Discount USD | Notes Payable, Related Parties, Current USD |
|---|---|---|---|---|---|
| 2026-06-30 | (m) | $1.65M | (m) | (m) | (m) |
| 2026-03-31 | (m) | $1.65M | (m) | (m) | (m) |
| 2025-12-31 | (m) | $1.65M | (m) | (m) | (m) |
| 2025-09-30 | (m) | $1.65M | (m) | (m) | (m) |
| 2025-06-30 | (m) | $1.65M | (m) | (m) | (m) |
| 2025-03-31 | (m) | $1.65M | (m) | (m) | (m) |
| 2024-12-31 | (m) | $1.65M | (m) | (m) | (m) |
| 2024-09-30 | (m) | $1.65M | (m) | (m) | (m) |
| 2024-06-30 | (m) | $1.65M | (m) | (m) | (m) |
| 2024-03-31 | (m) | $1.65M | (m) | (m) | (m) |
| 2023-12-31 | $80.71M | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $1.63M | (m) | $19.27K | (m) |
| 2023-09-30 | $625.69K | $625.69K | (m) | (m) | (m) |
| 2023-06-30 | $625.69K | $625.69K | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | $0.00 | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) | $81.53K |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B |